Posts In: Gubba Pharma In E News

Dr Reddys In S&P Global Sustainability Yearbook For 2nd

February 16, 2022 Gubba Pharma In E News

Dr. Reddy’s Laboratories Ltd. has announced two major back-to-back recognitions in sustainability and gender equality. Dr. Reddy’s is one of seven Indian companies in Bloomberg’s...

Continue Reading

Sun Pharma launches dry eye treatment product in Canada

February 16, 2022 Gubba Pharma In E News

Sun Pharma said its subsidiary has launched Cequa, a new treatment for dry eye disease, in Canada. Sun Pharma Canada Inc, a wholly-owned subsidiary of...

Continue Reading

Glenmark Pharma arm gets final USFDA approval for blood pressure drug

February 9, 2022 Gubba Pharma In E News

Generic Bisoprolol Fumarate and Hydrochlorothiazide are tablets used to treat high blood pressure. Glenmark Pharmaceuticals Ltd on January 27 said its U.S. subsidiary has received...

Continue Reading

Sun Pharma plans in-licensing, buyouts to expand speciality business

February 9, 2022 Gubba Pharma In E News

Sun Pharma, the India’s giant drugmaker, the company is looking for possible in-licensing opportunities and even acquisitions to bolster its global specialty business, citing the...

Continue Reading

Panacea Biotec sells domestic formulation assets to Mankind Pharma for Rs 1,908 crore

February 9, 2022 Gubba Pharma In E News

Panacea Biotec said that it has entered into an agreement to sell its formulation business in India and Nepal to Mankind Pharma for Rs 1908...

Continue Reading

Bharat Biotech Manufactured Nasal Vaccine Could Be Game-Changer If It Provides Mucosal Immunity: AIIMS Doctor

February 2, 2022 Gubba Pharma In E News

The nasal vaccine, manufactured by Hyderabad-based Bharat Biotech, could be a game-changer if it provides mucosal immunity, said a senior epidemiologist of All India Institute...

Continue Reading

Lupin partners with Exeltis for marketing its specialty drug Solosec in US.

February 2, 2022 Gubba Pharma In E News

Drug maker Lupin said it has entered into an agreement with Exeltis USA to promote the former’s specialty antibacterial drug Solosec in the US market....

Continue Reading

Philips introduces first at-home, 12-lead ECG integrated solution for decentralized clinical trials

February 2, 2022 Gubba Pharma In E News

Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during...

Continue Reading

CII Cold Chain Logistics for Pharma Industry 2022

January 25, 2022 Gubba Pharma In E News

CII (Confederation of Indian Industry) organised a conference on Cold Chain Logistics for Pharma Industry to be held 20 & 21 Jan 2022 through virtual...

Continue Reading